Hacker News new | ask | show | jobs
by PragmaticPulp 1806 days ago
4% versus 2% in the longer term study.

> Although this is pure randomness with such close measurements.

That's not how this works at scale. We need larger studies, yes, but you can't simply dismiss a doubling of long-term symptom reports.

At population scale, even a 1-2% incidence means millions of people.

2 comments

It is pretty weak though. There were only 109 seropositive kids in the follow-up according to the table, so you're talking about 2 more kids reporting a cough or headache as the entire basis of your concern.
There is no doubling here – only random noise.